Gemenetzi K, Agathangelidis A, Zaragoza-Infante L, Sofou E, Papaioannou M, Chatzidimitriou A, et al. B cell receptor immunogenetics in B cell lymphomas: immunoglobulin genes as key to ontogeny and clinical decision making. Front Oncol. 2020;10:67.

Article  PubMed  PubMed Central  Google Scholar 

Van Roosbroeck K, Ferreiro JF, Tousseyn T, van der Krogt JA, Michaux L, Pienkowska-Grela B, et al. Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies. Genes Chromosomes Cancer. 2016;55:428–41.

Article  PubMed  Google Scholar 

Roemer MG, Advani RH, Ligon AH, Natkunam Y, Redd RA, Homer H, et al. PD-L1 and PD-L2 genetic alterations define classical hodgkin lymphoma and predict outcome. J Clin Oncol. 2016;34:2690–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Re V, Caggiari L, Repetto O, Mussolin L, Mascarin M. Classical Hodgkin’s lymphoma in the era of immune checkpoint inhibition. J Clin Med. 2019;8:1596.

Article  PubMed  PubMed Central  Google Scholar 

Wren D, Walker BA, Brüggemann M, Catherwood MA, Pott C, Stamatopoulos K, et al. Comprehensive translocation and clonality detection in lymphoproliferative disorders by next-generation sequencing. Haematologica. 2017;102:e57–e60.

Article  PubMed  PubMed Central  Google Scholar 

Ma L, Guo H, Zhao Y, Liu Z, Wang C, Bu J, et al. Liquid biopsy in cancer current: status, challenges and future prospects. Signal Transduct Target Ther. 2024;9:336.

Article  PubMed  PubMed Central  Google Scholar 

Bravetti C, Degaud M, Armand M, Sourdeau E, Mokhtari K, Maloum K, et al. Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphoma. Br J Haematol. 2023;201:1088–96.

Article  CAS  PubMed  Google Scholar 

Guan T, Zhang M, Liu X, Li J, Xin B, Ren Y, et al. Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma. Front Oncol. 2022;12:1003957.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keller L, Belloum Y, Wikman H, Pantel K. Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond. Br J Cancer. 2021;124:345–58.

Article  PubMed  Google Scholar 

Liang JH, Wu YF, Shen HR, Li Y, Liang JH, Gao R, et al. Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma. Leukemia. 2024;38:1541–52.

Article  CAS  PubMed  Google Scholar 

Raman L, Van der Linden M, De Vriendt C, Van den Broeck B, Muylle K, Deeren D, et al. Shallow-depth sequencing of cell-free DNA for Hodgkin and diffuse large B-cell lymphoma (differential) diagnosis: a standardized approach with underappreciated potential. Haematologica. 2022;107:211–20.

Article  CAS  PubMed  Google Scholar 

Wright GW, Huang DW, Phelan JD, Coulibaly ZA, Roulland S, Young RM, et al. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications. Cancer Cell. 2020;37:551–68.e14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Mansour M, Saif SA, Alharbi Z, Alhwaity AS, Almasrahi A, Alnejadi W, et al. The outcomes of diffuse large B-cell lymphoma patients with synchronous and early central nervous system involvement: a single-center experience. Asian Pac J Cancer Prev. 2023;24:623–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720–48.

Article  PubMed  PubMed Central  Google Scholar 

Allahyar A, Pieterse M, Swennenhuis J, Los-de Vries GT, Yilmaz M, Leguit R, et al. Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing. Nat Commun. 2021;12:3361.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeng Y, Wei R, Bao L, Xue T, Qin Y, Ren M, et al. Characteristics and clinical value of MYC, BCL2, and BCL6 rearrangement detected by next-generation sequencing in DLBCL. Am J Surg Pathol. 2024;48:919–29.

Article  PubMed  PubMed Central  Google Scholar 

Wu X, Chen S, Chen P, Zhang H, Zhang L, Wang P, et al. IGH::CD274 (PD-L1) rearrangement in diffuse large B cell lymphoma and its therapeutic implication. EJHaem. 2023;4:442–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurtz DM, Green MR, Bratman SV, Scherer F, Liu CL, Kunder CA, et al. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 2015;125:3679–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roschewski M, Dunleavy K, Pittaluga S, Moorhead M, Pepin F, Kong K, et al. Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study. Lancet Oncol. 2015;16:541–9.

Article  PubMed  PubMed Central  Google Scholar 

Zhang X, Yang L, Zhu M, Zhao X, Xiao Y, Pang J, et al. The clinical utility of plasma circulating tumor DNA in the diagnosis and disease surveillance in non-diffuse large B-cell non-Hodgkin lymphomas. Future Oncol. 2024;20:3107–17.

Article  CAS  PubMed  Google Scholar 

Rossi D, Diop F, Spaccarotella E, Monti S, Zanni M, Rasi S, et al. Diffuse large B-cell lymphoma genotyping on the liquid biopsy. Blood. 2017;129:1947–57.

Article  CAS  PubMed  Google Scholar 

Li M, Jia Y, Xu J, Cheng X, Xu C. Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience. Ann Hematol. 2017;96:1343–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin-Alonso C, Tabrizi S, Xiong K, Blewett T, Sridhar S, Crnjac A, et al. Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies. Science. 2024;383:eadf2341.

Article  CAS  PubMed  PubMed Central  Google Scholar